Publication: A natural plant-derived dihydroisosteviol prevents cholera toxin-induced intestinal fluid secretion
Issued Date
2008-02-01
Resource Type
ISSN
15210103
00223565
00223565
Other identifier(s)
2-s2.0-38749131189
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Pharmacology and Experimental Therapeutics. Vol.324, No.2 (2008), 798-805
Suggested Citation
Prapapimon Pariwat, Sureeporn Homvisasevongsa, Chatchai Muanprasat, Varanuj Chatsudthipong A natural plant-derived dihydroisosteviol prevents cholera toxin-induced intestinal fluid secretion. Journal of Pharmacology and Experimental Therapeutics. Vol.324, No.2 (2008), 798-805. doi:10.1124/jpet.107.129288 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/19880
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
A natural plant-derived dihydroisosteviol prevents cholera toxin-induced intestinal fluid secretion
Other Contributor(s)
Abstract
Stevioside and its major metabolite, steviol, have been reported to affect ion transport in many types of tissues, such as the kidney, pancreas, and intestine. The effect of stevioside, steviol, and its analogs on intestinal Cl- secretion was investigated in a human T84 epithelial cell line. Short-circuit current measurements showed that steviol and analogs isosteviol, dihydroisosteviol, and isosteviol 16-oxime inhibited in a dose-dependent manner forskolin-induced Cl- secretion with IC50 values of 101, 100, 9.6, and 50 μM, respectively, whereas the parent compound stevioside had no effect. Apical Cl- current measurement indicated that dihydroisosteviol targeted the cystic fibrosis transmembrane regulator (CFTR). The inhibitory action of dihydroisosteviol was reversible and was not associated with changes in the intracellular cAMP level. In addition, dihydroisosteviol did not affect calcium-activated chloride secretion and T84 cell viability. In vivo studies using a mouse closed-loop model of cholera toxin-induced intestinal fluid secretion showed that intraluminal injection of 50 μM dihydroisosteviol reduced intestinal fluid secretion by 88.2% without altering fluid absorption. These results indicate that dihydroisosteviol and similar compounds could be a new class of CFTR inhibitors that may be useful for further development as antidiarrheal agents. Copyright © 2008 by The American Society for Pharmacology and Experimental Therapeutics.